RxDoctor Payments Data

Jose Condado Contreras, MD

Interventional Cardiology · Round Rock, TXNPI 1245468545

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Edwards Lifesciences at 57.5% of the total. 2025 is the largest year on record at $22,491, more than ten times the $1,077 reported in 2019.

$60,319in general payments, 2019–2025

Across 529 payments — averaging $114.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$35K
  • Medtronic$16K
  • Shockwave Medical, Inc$2K
  • Inari Medical, Inc.$2K
  • Abbott$1K
  • Boston Scientific$678
  • plus $2K from 16 others

What the payments were for

  • Consulting fees$14,71524%
  • Speaking & faculty fees$3,7636%
  • Travel & lodging$18,68031%
  • Food & beverage$23,16238%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,319 in reported general payments places this provider in the 85th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas →

Medicare billing

Part B allowed, 2024
$230,449
Medicare patients
1,327
Services billed
2,933

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban136$171,395
JardianceEmpagliflozin52$64,688
XareltoRivaroxaban14$11,729
ClopidogrelClopidogrel Bisulfate158$3,377
Metoprolol Succinate127$2,298
Atorvastatin Calcium166$1,975
Rosuvastatin Calcium93$1,511
Losartan Potassium97$1,439
Carvedilol100$1,388
Diltiazem 24hr Er (Cd)Diltiazem Hcl31$1,019
Amiodarone Hcl32$630
Digoxin18$628
Valsartan24$623
Furosemide96$585
Spironolactone65$536

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Round Rock

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →